NCT05910970 2024-01-23
PREVENT-2
Guangxi Medical University
Phase 3 Unknown
Clinical Trials
7 trialsNCT05220020 2022-05-19
TACE Combined With Lenvatinib Versus TACE Sequential Lenvatinib in the Treatment of Intermediate/Advanced Liver Cancer
Sun Yat-sen University
Phase 3 Unknown
NCT05056337 2021-09-24
Toripalimab in Combination With Lenvatinib and TACE for Conversion Therapy in Patients With Potentially Resectable HCC
Shanghai Zhongshan Hospital
Phase 3 Unknown
NCT04229355 2021-02-09
DEB-TACE Plus Lenvatinib or Sorafenib or PD-1 Inhibitor for Unresectable Hepatocellular Carcinoma
Guangxi Medical University
Phase 3 Unknown
NCT04053972 2019-08-13
The Impact on Recurrence Risk of Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
Sun Yat-sen University
Phase 3 Unknown
NCT04053985 2019-08-13
The Efficacy of Transarterial Chemoinfusion (TAI) Combine Lenvatinib in Advanced Hepatocellular Carcinoma (HCC)
Sun Yat-sen University
Phase 3 Unknown
NCT03775395 2019-01-03
HAIC Plus Lenvatinib vs HAIC Plus Sorafenib for Advanced HCC
Sun Yat-sen University
Phase 3 Unknown